Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen
Go back to Biogen Provides Regulatory Update on High Dose Regimen of Nusinersen| BIOGEN IDEC Inc. (NASDAQ: BIIB) | Delayed: 205.99 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $205.99 | 52 Week High | $333.65 | |||
| Open | $205.99 | 52 Week Low | $223.02 | |||
| Day High | $205.99 | P/E | 26.38 | |||
| Day Low | $205.99 | EPS | $7.81 | |||
| Volume | 279 | |||||
| (NASDAQ: IONS) | Delayed: 54.39 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $54.39 | 52 Week High | $62.68 | |||
| Open | $54.39 | 52 Week Low | $19.59 | |||
| Day High | $54.39 | P/E | N/A | |||
| Day Low | $54.39 | EPS | $0.00 | |||
| Volume | 1,126 | |||||
